Release Date: 09/05/23 09:14 Summary: Clarification Regarding Investor Webinar Price Sensitive: Yes Download Document 140.25KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%